Pharma
- Prior to the April 28 federal election, Ottawa secured pharmacare agreements with four jurisdictions: British Columbia, Manitoba, the Yukon, and Prince Edward Island.
- Prior to the April 28 federal election, Ottawa secured pharmacare agreements with four jurisdictions: British Columbia, Manitoba, the Yukon, and Prince Edward Island.
Become a Political Insider
Sign up for Today's Headlines newsletter now
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
- The results of The Hill Times’ 2024 year-end poll are in. Liberal MP Sean Fraser scores a hat trick and takes the ‘Most Valuable
- The results of The Hill Times’ 2024 year-end poll are in. Liberal MP Sean Fraser scores a hat trick and takes the ‘Most Valuable
- The results of The Hill Times’ 2024 year-end poll are in. Liberal MP Sean Fraser scores a hat trick and takes the ‘Most Valuable
- Feds looking to find $15.8-billion in savings through 'Refocus Government Spending' initiative as pressure mounts for Canada to boost defence spending.
- Feds looking to find $15.8-billion in savings through 'Refocus Government Spending' initiative as pressure mounts for Canada to boost defence spending.
- Feds looking to find $15.8-billion in savings through 'Refocus Government Spending' initiative as pressure mounts for Canada to boost defence spending.
- Treasury Board President Anita Anand says departments are ‘okay for the next three to four weeks’ if a vote on supplementary estimates is delayed

- Treasury Board President Anita Anand says departments are ‘okay for the next three to four weeks’ if a vote on supplementary estimates is delayed
- Treasury Board President Anita Anand says departments are ‘okay for the next three to four weeks’ if a vote on supplementary estimates is delayed

- Focus on embracing the rapid pace of scientific discovery, letting innovation drive policy, and fostering collaboration across the health-care system.
- Focus on embracing the rapid pace of scientific discovery, letting innovation drive policy, and fostering collaboration across the health-care system.
- Focus on embracing the rapid pace of scientific discovery, letting innovation drive policy, and fostering collaboration across the health-care system.
- The Senate Social Affairs, Science, and Technology Committee will have just four weeks to study the pharmacare legislation before its scheduled third reading vote
- The Senate Social Affairs, Science, and Technology Committee will have just four weeks to study the pharmacare legislation before its scheduled third reading vote
- The Senate Social Affairs, Science, and Technology Committee will have just four weeks to study the pharmacare legislation before its scheduled third reading vote
- The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
- The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
- The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
- With a current 'hodgepodge' of bills before Parliament, the Liberals may want to form a cohesive narrative through their fall legislative agenda, says Yaroslav
- With a current 'hodgepodge' of bills before Parliament, the Liberals may want to form a cohesive narrative through their fall legislative agenda, says Yaroslav
- With a current 'hodgepodge' of bills before Parliament, the Liberals may want to form a cohesive narrative through their fall legislative agenda, says Yaroslav
- Patient groups’ involvement should be built into the program, not just a one-time pre-consultation.
- Patient groups’ involvement should be built into the program, not just a one-time pre-consultation.
- Patient groups’ involvement should be built into the program, not just a one-time pre-consultation.
- The big news in health care these days is national pharmacare. This is surely welcome news for those of us living with any chronic
- The big news in health care these days is national pharmacare. This is surely welcome news for those of us living with any chronic
- The big news in health care these days is national pharmacare. This is surely welcome news for those of us living with any chronic
- Focusing on a list of the most commonly prescribed clinically-important drugs could save billions of dollars, both directly in terms of drug budget, and
- Focusing on a list of the most commonly prescribed clinically-important drugs could save billions of dollars, both directly in terms of drug budget, and
- Focusing on a list of the most commonly prescribed clinically-important drugs could save billions of dollars, both directly in terms of drug budget, and
- Pharmacare is the most innovative and important health policy legislation in decades. To get it right, the federal government must directly engage with patients.
- Pharmacare is the most innovative and important health policy legislation in decades. To get it right, the federal government must directly engage with patients.
- Pharmacare is the most innovative and important health policy legislation in decades. To get it right, the federal government must directly engage with patients.
- Green Party Leader Elizabeth May and NDP Leader Jagmeet Singh have done their part as responsible opposition critics on this policy. Now it’s Pierre
- Green Party Leader Elizabeth May and NDP Leader Jagmeet Singh have done their part as responsible opposition critics on this policy. Now it’s Pierre
- Green Party Leader Elizabeth May and NDP Leader Jagmeet Singh have done their part as responsible opposition critics on this policy. Now it’s Pierre
- Canadians have the chance to consider whether to view access to medicines as a pillar of healthcare, or simply an add-on service.
- Canadians have the chance to consider whether to view access to medicines as a pillar of healthcare, or simply an add-on service.
- Canadians have the chance to consider whether to view access to medicines as a pillar of healthcare, or simply an add-on service.
- Re: “First phase of pharmacare must not ‘create new gaps’ in existing coverage, says lobbyists (The Hill Times, April 1). I strongly endorse the
Opinion | April 8, 2024
Opinion | April 8, 2024
- Re: “First phase of pharmacare must not ‘create new gaps’ in existing coverage, says lobbyists (The Hill Times, April 1). I strongly endorse the
Opinion | April 8, 2024
- Re: “First phase of pharmacare must not ‘create new gaps’ in existing coverage, says lobbyists (The Hill Times, April 1). I strongly endorse the
- Using insulin is always challenging, so access to a broad range of appropriate options is vital.
- Using insulin is always challenging, so access to a broad range of appropriate options is vital.
- Using insulin is always challenging, so access to a broad range of appropriate options is vital.
- Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.
- Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.
- Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.
- The proposed new law would likely prohibit Canadians from purchasing supplemental insurance to cover drugs not covered (or only partially covered) by pharmacare.
- The proposed new law would likely prohibit Canadians from purchasing supplemental insurance to cover drugs not covered (or only partially covered) by pharmacare.
- The proposed new law would likely prohibit Canadians from purchasing supplemental insurance to cover drugs not covered (or only partially covered) by pharmacare.